Cargando…
Bispecific Antibodies in Hematological Malignancies: A Scoping Review
SIMPLE SUMMARY: Bispecific T-cell engagers (BiTEs) and bispecific antibodies (BiAbs) have emerged as novel therapeutic modalities in the treatment of advanced hematological malignancies. BiTEs and BiAbs redirect T cells to attack tumors and facilitate T-cell-mediated cell death. Blinatumomab was the...
Autores principales: | Omer, Mohamed H., Shafqat, Areez, Ahmad, Omar, Alkattan, Khaled, Yaqinuddin, Ahmed, Damlaj, Moussab |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526328/ https://www.ncbi.nlm.nih.gov/pubmed/37760519 http://dx.doi.org/10.3390/cancers15184550 |
Ejemplares similares
-
Effect of SARS-CoV-2 Mutations on the Efficacy of Antibody Therapy and Response to Vaccines
por: Yaqinuddin, Ahmed, et al.
Publicado: (2021) -
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
por: Shafqat, Areez, et al.
Publicado: (2022) -
Fertilization, Oocyte Activation, Calcium Release and Epigenetic Remodelling: Lessons From Cancer Models
por: Shafqat, Areez, et al.
Publicado: (2022) -
Corrigendum: Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023) -
Reprogramming the immunosuppressive tumor microenvironment: exploiting angiogenesis and thrombosis to enhance immunotherapy
por: Shafqat, Areez, et al.
Publicado: (2023)